Eligibility Determination
"Eligibility Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Criteria to determine eligibility of patients for medical care programs and services.
| Descriptor ID |
D004608
|
| MeSH Number(s) |
N04.452.264
|
| Concept/Terms |
Eligibility Determination- Eligibility Determination
- Determination, Eligibility
- Determinations, Eligibility
- Eligibility Determinations
Eligibility Certification- Eligibility Certification
- Certification, Eligibility
- Certifications, Eligibility
- Eligibility Certifications
|
Below are MeSH descriptors whose meaning is more general than "Eligibility Determination".
Below are MeSH descriptors whose meaning is more specific than "Eligibility Determination".
This graph shows the total number of publications written about "Eligibility Determination" by people in this website by year, and whether "Eligibility Determination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Eligibility Determination" by people in Profiles.
-
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group. Clin Lung Cancer. 2020 07; 21(4):295-307.
-
Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria. J Thorac Oncol. 2018 06; 13(6):748-751.
-
Recruitment of African American women to a walking program: eligibility, ineligibility, and attrition during screening. Res Nurs Health. 2006 Jun; 29(3):176-89.
-
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biol Psychiatry. 2003 Oct 15; 54(8):806-17.
-
Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum. 2003 Feb; 48(2):313-8.